期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 87, 期 2, 页码 176-183出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2009.10.018
关键词
Apelin; APJ; Adiponectin; Adipose tissue; Placenta; Gestational diabetes mellitus
资金
- State Committee for Scientific Research [KBN 2 PO5E 08829]
Aims and methods: Apelin is a novel adipokine identified as an endogenous ligand of the G protein-coupled receptor APJ. In this study we compared plasma apelin concentrations in 101 patients with gestational diabetes (GDM) and 101 women with normal glucose tolerance (NGT) between 24 and 32 weeks of gestation (Group 1), as well as in 20 women with GDM and 16 subjects with NGT at term (Group 2). Apelin and APJ mRNA expression in subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and placental tissue were also measured in Group 2, using quantitative real-time PCR. Results: There were no significant differences in plasma apelin levels between the women with GDM and NGT (Group 1: 1555.6 [1281.2-1804.2] pg/ml vs 1656.5 [1430.2-1852.1] pg/ml, Group 2: 1607.9 [1453.4-1768.7] pg/ml vs; 1493.8 [1316.8-1956.7] pg/ml) nor in apelin and APJ mRNA expression in SAT, VAT and placental tissue. Apelin mRNA expression was approximately 10 fold higher in placental than in adipose tissue (p < 0.0001). Apelin and APJ mRNA expression correlated significantly in SAT (R = 0.45, p = 0.03), VAT (R = 0.69, p = 0.003) and placental tissue (R = 0.37, p = 0.03). Conclusions: No associations between circulating apelin or apelin/APJ mRNA expression and GDM or the indices of insulin resistance were noted in our study. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据